ARTICLE | Clinical News
Reolysin: Completed Phase II enrollment
February 23, 2015 8:00 AM UTC
Oncolytics Biotech said the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) completed enrollment of 103 patients in an open-label, Canadian Phase II trial comparing IV Reolysin p...